LIF and myeloid sarcoma: In humans, microarray analyses of non-lesioned motor cortex tissue have shown that components of the Ciliary neurotrophic factor (CNTF)/Leukemia inhibitory factor (LIF) signalling pathway are more highly expressed in MS patients than controls, potentially representing an endogenous protective response to limit neural injury in neuro-inflammatory diseases [9].